Elite in Polymyalgia Rheumatica

Divi K. Cornec

CHU De Brest
Brest, FR 
Elite in Polymyalgia Rheumatica
CHU De Brest
Brest, FR 
OverviewLocationsClinical Research

Overview

Divi Cornec practices in Brest, France. Ms. Cornec is rated as an Elite expert by MediFind in the treatment of Polymyalgia Rheumatica. Her top areas of expertise are Dry Mouth, Sjogren Syndrome, Dry Eye Syndrome, Polymyalgia Rheumatica, and Tissue Biopsy.

Her clinical research consists of co-authoring 199 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 18 articles in the study of Polymyalgia Rheumatica.

Gender
Female

Locations

CHU de Brest
Brest, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase IIa Randomized, Double Blind, Placebo Controlled, Multiple Dose Study on ABX464 in Combination With Methotrexate (MTX), in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have Inadequate Response to MTX or/and to Anti-Tnfα, or Intolerance to Anti-Tnfα
Phase IIa Randomized, Double Blind, Placebo Controlled, Multiple Dose Study on ABX464 in Combination With Methotrexate (MTX), in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have Inadequate Response to MTX or/and to Anti-Tnfα, or Intolerance to Anti-Tnfα
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Drug
Study Drugs: ABX464, Methotrexate
Study Phase: Phase 2
A Follow-up Phase 2a Open-label Study to Evaluate the Long-term Safety and Efficacy Profile of ABX464 in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Follow-up Phase 2a Open-label Study to Evaluate the Long-term Safety and Efficacy Profile of ABX464 in Patients With Moderate to Severe Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: January 26, 2023
Intervention Type: Drug
Study Drug: ABX464
Study Phase: Phase 2
Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis
Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: April 19, 2019
View 2 Less Clinical Trials

198 Total Publications

Fourteen ways to make B cells the most interesting target in systemic lupus erythematosus
Fourteen ways to make B cells the most interesting target in systemic lupus erythematosus
Journal: La Revue de medecine interne
Published: September 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cornec's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 10 Advanced Conditions
View All 28 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile